1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: September 6-12, 2026
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: September 6-12, 2026

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Kyle Diamantas, J.D., Acting Commissioner of Food and Drugs
Event Date: 09/08/2026
Location: Silver Spring, MD
Subject: Modernization and Engagement Opportunities with CVM
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Animal Health Institute (AHI) representatives

Official Name: Sean R. Keveney, J.D., Chief Counsel
Event Date: 09/08/2026
Location: Washington, DC
Subject: Generic Rifximin
FDA Participant/Group: N/A
Non FDA Participant/Group: John Strom (Foley Hoag); Kelly Childress Lange (East End Group);

Event Date: 09/08/2026
Location: Washington, DC
Subject: Retatrutide
FDA Participant/Group: N/A
Non FDA Participant/Group: Hakim Anat (Lilly Pharmaceutical);

Event Date: 09/09/2026
Location: Washington, DC
Subject: Pharmaceutics International
FDA Participant/Group: N/A
Non FDA Participant/Group: Bethany Hills, Brent Wible, Joel Cohen (White & Case);

Event Date: 09/10/2026
Location: Washington, DC
Subject: Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Alison Manhoff, Daniel Siegfried, Hakim Anat, Josh Tomas O’Harra (Lilly Pharmaceutical); James Johnson, S. Griffin (Sidley Austin);

Event Date: 09/10/2026
Location: Washington, DC
Subject: American Association of Orthodontists
FDA Participant/Group: N/A
Non FDA Participant/Group: Alexandra Campau (Cozen O'Connor PC);

Official Name: Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs
Event Date: 09/09/2026
Location: Washington, DC
Subject: Homeopathy Trade Associations Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: OHM Pharma, Grato Holdings, and Health Freedom Defense Fund representatives

Official Name: Lowell Zeta, J.D., Deputy Commissioner for Strategic Initiatives
Event Date: 09/09/2026
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: LUKE HALL;
Non FDA Participant/Group: Bill Capra, Mags Maher, Mark Lee (N-Power Medicine);

Event Date: 09/10/2026
Location: Silver Spring, MD
Subject: Introductory Meeting
FDA Participant/Group: LUKE HALL; KARIM MIKHAIL;
Non FDA Participant/Group: Diane Balderson, Terry Pirovolakis, Trey Putnam (Elpida Therapeutics);

Event Date: 09/11/2026
Location: Virtual
Subject: Anitocabtagene Autoleucel (anito-cel)
FDA Participant/Group: KARIM MIKHAIL;
Non FDA Participant/Group: Dietmar Berger (Gilead Sciences); Cindy Perettie, Claire Esguerra (Kite Pharma);

Official Name: Donald A. Prater, D.V.M., Acting Deputy Commissioner for Food
Event Date: 09/08/2026
Location: Mexico City, Mexico
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Federal Commission for the Protection from Sanitary Risks, and the National Service of Agroalimentary Health, Safety, and Quality representatives

Official Name: Melanie Keller, M.B.A., Deputy Commissioner for Operations and Chief Operating Officer
No Significant Event

Official Name: Elizabeth Miller, Pharm.D., Associate Commissioner for Inspections and Investigations
Event Date: 09/10/2026
Location: Arlington, VA
Subject: Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and SupplieS (FASTPASS) Proposers’ Day
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, media, and other registered attendees

Official Name: Karim Mikhail, B.Pharm, MSc, Director, Center for Biologics Evaluation and Research
No Significant Event

Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health
Event Date: 09/09/2026
Location: London, UK
Subject: National Commission into the Regulation of AI in Healthcare - Recommendations Launch Event; Panelist: Risk-Proportionate Regulation and Clear Paths to Market
FDA Participant/Group: ERIN CUTTS;
Non FDA Participant/Group: Industry, government, academia, and other stakeholders

Official Name: Michael Davis, M.D., Ph.D., Director, Center for Drug Evaluation and Research
Event Date: 09/10/2026
Location: Silver Spring, MD
Subject: Issues of Mutual Interest
FDA Participant/Group: ADAM FISHER; SARAH YIM; IILUN MURPHY; SARAH IBRAHIM;
Non FDA Participant/Group: Giuseppe Randazzo, Mark Ratner, Robert Gaines, Scott Kuzner (Association for Accessible Medicines (AAM));

Official Name: Bret Koplow, Ph.D., J.D., Director, Center for Tobacco Products
Event Date: 09/11/2026
Location: Lisbon, Portugal
Subject: Global Tobacco and Nicotine Forum (GTNF) 2026; Keynote Address: Tobacco Regulation in the United States: Strategic Priorities for Advancing Public Health by Reducing Harm
FDA Participant/Group: ANNE RANCOURT;
Non FDA Participant/Group: Manufacturers, consulting organizations, academia, and other registered attendees

Official Name: Timothy C. Schell, Ph.D., Director, Center for Veterinary Medicine
No Significant Event
 

Back to Top